Ethamcip 500 Tablet contains Ethamsylate 500mg, an effective hemostatic agent used to reduce bleeding by promoting platelet adhesion and stabilizing capillary walls. It is commonly prescribed to manage and prevent excessive bleeding in various clinical conditions such as menorrhagia, postoperative hemorrhage, dental extractions, and capillary fragility disorders. Ethamsylate works by enhancing the initial phase of hemostasis without affecting blood coagulation parameters, making it a safer option for patients prone to bleeding. The tablet is typically administered orally, with dosage and duration depending on the severity and type of bleeding disorder. Ethamcip 500 is well-tolerated, with minimal side effects, which may include mild gastrointestinal discomfort or allergic reactions in rare cases. It is important to use this medication under medical supervision, especially in patients with known hypersensitivity or those on anticoagulant therapy, to avoid potential interactions. Ethamcip 500 Tablet offers a reliable solution for controlling bleeding episodes, improving patient outcomes in surgical, gynecological, and hematological settings. Always follow the prescribed dosage and consult a healthcare professional if symptoms persist or worsen.